Kerala Governor reappoints Mohanan Kunnummal as KUHS-VC

Thiruvananthapuram: In a notable development, the Governor of Kerala, Arif Mohammed Khan, reappointed Mohanan Kunnummal as the Vice Chancellor of the Kerala University of Health Sciences (KUHS) on Thursday just as Kunnummal was about to conclude his five-year term in office.

The reappointment letter issued by Raj Bhavan states that Kunnummal can serve as the Vice Chancellor for five years or until he reaches the age of 70. Notably, the order also mentions that he will maintain his role as VC of Kerala University, a position he has held for the past two years.

The first person to receive reappointment as VC was Kannur University’s former VC Gopinath Ravindran. Kunnummal’s reappointment makes him the second individual to receive reappointment in Kerala. However, in 2023, when the Supreme Court invalidated the reappointment of Ravidran, he was compelled to step down from his position. This ruling was followed by the claims from the governor that his decision to grant Ravindran a second term was made under pressure from the state government.

Also Read: Dr Achal Gulati takes charge as VC of Mahatma Gandhi University of Medical Sciences & Technology, Jaipur

As per the recent media report by the Times of India, Raj Bhavan also withdrew the search committee constituted by the governor for KUHS. The high court had stayed the search committee after the govt challenged the governor’s authority to constitute the search committee on his own.

Additionally, the initial appointment of Kunnummal sparked controversy as the governor selected him while overlooking the candidates recommended by the government in 2019. Twelve of the fourteen universities in Kerala are currently led by ad hoc Vice Chancellors due to the ongoing political tensions between the government and the governor.

The term of the Saji Gopinath, VC of the Kerala University of Digital Sciences, Innovation, and Technology, is set to expire by the end of October 2024, raising further questions about the stability and governance of Kerala’s higher education institutions. 

Also Read: Dr M K Ramesh appointed new VC of RGUHS

Powered by WPeMatico

Philips, Medtronic Ink Advocacy Partnership to Enhance Stroke Care Access

Netherlands: Royal Philips, a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, announced a strategic advocacy partnership. Delivering timely stroke care is crucial to saving lives and reducing long-term disability. As leaders in stroke diagnosis and treatment, the two organizations are advocating on raising awareness around the potential health and economic benefits for patients, their families and societies of improving access to timely stroke diagnosis and treatment.

Philips and Medtronic Neurovascular also further expanded and strengthened their partnerships with the World Stroke Organization (WSO) by joining the newly established WSO Advocacy Coalition. This WSO-led coalition brings together diverse stakeholders, including healthcare professionals, patient groups, and policymakers, to develop coordinated strategies that address the global burden of stroke. The two companies are already working together with the World Stroke Organization to share the latest research, exchange best practices, drive improvements and advance the stroke policy agenda.

A stroke is typically an acute event, mostly caused by a blockage in a blood vessel in the brain that prevents adequate blood supply to brain tissue and leads to permanent loss of brain cells. It is a leading cause of disability and death worldwide, affecting an estimated 12 million people globally every year, including an increasing number of young people. The direct and indirect costs are conservatively estimated to be around USD 900 billion annually and are expected to almost double over the next 25 years.

Also Read: Medtronic gets USFDA approval for inceptive closed loop spinal cord stimulator for chronic pain

Philips and Medtronic Neurovascular are advocating for a global network of stroke care centres that can deliver comprehensive care, from early diagnosis to rehabilitation. Their joint efforts focus on three key areas:

Raising awareness: Promoting public understanding of stroke symptoms and the importance of seeking immediate care.

Improving access to treatment: Expanding the number of stroke-ready hospitals and providing training to healthcare professionals on the latest interventional techniques.

Leveraging technology and innovation: Utilizing advanced imaging and digital health tools to create integrated stroke care systems that support early diagnosis, effective treatment, and post-procedure monitoring.

The collaboration will be highlighted at the upcoming World Stroke Congress (October 23-26) in Abu Dhabi, where Philips and Medtronic Neurovascular will host a Stroke Advocacy roundtable session. This initiative builds on their joint presence at events such as the United Nations General Assembly and the World Health Assembly, where they emphasized the need for increased investments in stroke care infrastructure and supportive policy changes.

“Our new partnership with Medtronic Neurovascular and the ongoing collaboration with the World Stroke Organization highlights our shared commitment to transforming stroke care. With advanced technologies and a focus on collaboration, the time to act is now to ensure that stroke patients have timely stroke care — no matter where they live,” said Carla Goulart Peron, chief medical officer, Philips.

“Stroke care is a race against time, and by joining forces with Philips, we can help accelerate access to life-saving treatments like mechanical thrombectomy. Together, we are advocating for necessary investments in stroke care infrastructure to reduce the burden on patients and healthcare systems globally,” said Signe Haughton, chief of staff, senior director of medical & government affairs, Medtronic Neurovascular.

Philips’ partnership with the World Stroke Organization, established in 2023, has now been further expanded and strengthened by Philips’ involvement in the WSO Advocacy Coalition. While the initial partnership focused on improving access to high-quality stroke care globally, this new collaboration deepens Philips’ role in global stroke advocacy. By joining the WSO Advocacy Coalition, Philips is now part of a global network that actively works on healthcare policy, raise public awareness, and advocate for increased investment in stroke care infrastructure.

Royal Philips is a leading health technology company focused on improving people’s health and well-being through meaningful innovation.

Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions.

Powered by WPeMatico

When can doctors be held liable for medical negligence? Supreme Court clarifies

New Delhi: The Supreme Court recently stated that a medical professional may be held liable for medical negligence only when he lacks the requisite qualification or skill or fails to exercise the reasonable skill that he possesses while treating the patient.

“A medical professional may be held liable for negligence only when he is not possessed with the requisite qualification or skill or when he fails to exercise reasonable skill which he possesses in giving the treatment,” observed the Apex Court bench comprising Justice Pankaj Mithal.

Pointing out that actionable medical negligence involves three constituents (i) duty to exercise due care; (ii) breach of duty and (iii) consequential damage, the top court bench clarified that a simple lack of care or an error of judgment or an accident is not sufficient proof of negligence on the part of the medical professional as long as he/she follows the acceptable practice of the medical profession in discharge of his/her duties.

With this observation, the top court bench exonerated the Post Graduate Institute of Medical Education and Research (PGIMER) and its doctor from charges of medical negligence while providing treatment to a minor boy suffering from PTOSIS.

The Apex Court opined that none of the two essential conditions for establishing negligence were satisfied against the doctor and the hospital as no evidence was brought on record to prove that the doctor had not exercised due diligence, care, or skill which he possessed in operating the patient and giving treatment to him. 

Also Read: Surgeon Cannot be held responsible for gangrene: Consumer Court relief

Back in 1996, the complainant’s 6-year-old son was diagnosed with a congenital disorder in his left eye, also known as ‘PTOSIS’ or ‘Dropping eyelid’ and for this, a minor surgery was performed by the treating doctor- Dr Sud at PGI Chandigarh. The complainant alleged that there was no other defect in his son’s eye and both eyes had normal 6/9 equal vision.

Further, the complainant claimed that the physical deformity diagnosed as PTOSIS i.e. drooping eyelid could have been cured by a minor operation which required lifting of the left eyelid a little to make it of the same size as the right eye. However, allegedly, the said surgery was done in a most negligent manner and due to this, the eye’s condition further deteriorated after the surgery, instead of getting any better.

 Therefore, the complainant filed a consumer complaint before the State Commission and claimed a compensation of Rs 15,00,000 for the sufferings due to the doctor’s alleged negligence and further a sum of Rs 4,55,000 towards the cost of the treatment, loss of studies etc. 

On the other hand, the doctor and PGI claimed that the complainant was given proper treatment with due care during the operation and further submitted that the correction and reoccurrence of PTOSIS is a common complication of congenital PTOSIS which could have been set right by repeat surgery.

It was further submitted that the patient was not examined by Dr. Sud after January 1997 as he was taken for treatment to Guru Nanak Eye Centre, Delhi and Dr. Daljit Singh Hospital, Amritsar.

While considering the matter, the State Commission, after examining the records, concluded that the complainants failed to establish any negligence or carelessness on the part of the patient. It had noted that Dr. Sud was a duly qualified doctor possessing requisite professional skill and competence to perform the surgery and therefore, neither Dr. Sud nor the PGI could be held responsible for any negligence in the treatment.

However, the NCDRC partly reversed the findings of the State Commission based on the re-examination of the record of PGI which showed that before the surgery, the patient had a proper 6/9 vision in both the eyes and was suffering from a moderate PTOSIS with no history of double vision. However, post-surgery, the condition of PTOSIS deteriorated from moderate to severe and the patient’s vision also fell down from 6/9 in both eyes to 6/18. The patient also suffered from double vision post-surgery. Thus, the NCDRC held that the doctor was negligent in not giving proper treatment and careless in not performing the repeat surgery.

Accordingly, the NCDRC had held Dr. Sud and PGIMER jointly and severely liable for payment of compensation of Rs 3 lakh and Rs 50,000 as costs with 6% interest from the date of the complaint for the negligence in treatment. Challenging the NCDRC order, the doctor and the hospital approached the Supreme Court bench.

Taking note of the proceedings of the matter before the State Commission and the Apex Consumer Court, the Supreme Court bench noted that, “Deterioration of the condition of the patient post-surgery is not necessarily indicative or suggestive of the fact that the surgery performed or the treatment given to the patient was not proper or inappropriate or that there was some negligence in administering the same. In case of surgery or such treatment it is not necessary that in every case the condition of the patient would improve and the surgery is successful to the satisfaction of the patient.”

“It is very much possible that in some rare cases complications of such nature arise but that by itself does not establish any actionable negligence on part of the medical expert,” the bench further noted.

The Supreme Court bench observed that the NCDRC itself acknowledged that Dr. Sud had the necessary professional qualification and expertise to treat the patient but it granted the compensation only for the reason that he did not bring the requisite skill and care in the patient’s treatment.

Referring to this, the top court bench noted,

“The said finding is based on no evidence insofar as the complainants have not adduced any evidence to prove any negligence on part of the doctor rather have relied upon the medical records produced by the PGI. The said records merely demonstrate that post-surgery the condition of the patient had not improved but has deteriorated which as stated earlier may not be indicative of the negligence in the treatment of the patient.”

It further observed that actionable negligence in the context of medical profession involves three constituents (i) duty to exercise due care; (ii) breach of duty and (iii) consequential damage.

“However, a simple lack of care, an error of judgment or an accident is not sufficient proof of negligence on part of the medical professional so long as the doctor follows the acceptable practice of the medical profession in discharge of his duties. He cannot be held liable for negligence merely because a better alternative treatment or course of treatment was available or that more skilled doctors were there who could have administered better treatment,” it noted.

“When reasonable care, expected of the medical professional, is extended or rendered to the patient unless contrary is proved, it would not be a case for actionable negligence,” it clarified.

Further referring to the judgment in the case of Bolam v. Friern Hospital Management Committee and the Supreme Court order in the case of Jacob Mathews v. State of Punjab and Another, the bench noted, “The complainant has not adduced any evidence to establish that Dr. ***Sud or the PGI were guilty of not exercising the expertise or the skill possessed by them, so as to hold them liable for negligence. No evidence was produced of any expert body in the medical field to prove that requisite skill possessed by Dr. ***was not exercised by him in discharge of his duties.”

“In other words, simply for the reason that the patient has not responded favourably to the surgery or the treatment administered by a doctor or that the surgery has failed, the doctor cannot be held liable for medical negligence straightway by applying the doctrine of Res Ipsa Loquitor unless it is established by evidence that the doctor failed to exercise the due skill possessed by him in discharging of his duties,” it further noted.

Opining that NCDRC not to have interfered with the findings and the impugned judgment and order of the State Commission so as to hold the doctor of the PGI negligent and to award compensation, the top court set aside the NCDRC order dated 24.08.2011 and restored the order of the State Commission.

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/dr-neeraj-sud-vs-jaswinder-singh-258361.pdf

Also Read: No Medical Negligence in Administering Anaesthesia- Consumer Court relief to UP Hospital, Doctors

Powered by WPeMatico

MBBS Seats doubled, 17 New Medical Colleges set up in UP: CM Yogi Adityanath

Maharajganj : The number of MBBS seats have doubled and 17 new medical colleges have been opened this year in the state of Uttar pradesh. This was recently announced by Uttar Pradesh Chief Minister Yogi Adityanath on Friday when he said medical education in the state is being strengthened.

Uttar Pradesh once had only 18 medical colleges across the country but today healthcare institutions have been established in 64 districts, he said, quotes PTI

He emphasised the remarkable transformation in healthcare in Uttar Pradesh, recalling how the BRD Medical College in Gorakhpur, which was once called an ‘bimaar’ (ill) state, today gives a healthy competition to the prestigious AIIMS Gorakhpur.

Addressing a gathering during the inauguration programme of KMC Medical College (PPP) in Maharajganj district, he mentioned that when he took charge of the office in 2017, the state lacked sufficient funds even for salaries, yet through teamwork and collective support, significant progress has been achieved.

Adityanath said that with the establishment of AIIMS in Gorakhpur, medical colleges have started in Kushinagar, Deoria, Basti, Siddharthnagar, Gonda, Bahraich, Sultanpur, Ambedkarnagar, Ayodhya, Pratapgarh.

For the remaining 6-7 districts, medical colleges will be established with a new policy, Adityanath said. “We will fulfil the resolution of ‘One District, One Medical College’.” Accusing the previous governments of “neglecting” and “overlooking” the Terai districts of the state, the chief minister asserted that today Maharajganj district is “no longer sidelined”.

“Ensuring good connectivity to these new medical colleges is a top priority for the government. Additionally, nursing and paramedical colleges are being developed across the state to strengthen the healthcare workforce,” the CM said.

Powered by WPeMatico

Porsche Crash Case: Maha Govt Approves Prosecution of Forensic Head, CMO, staff of Sassoon Hospital

Pune: In the latest update on the Porsche car crash case in Pune where the head of the Forensic Medicine department and Chief Medical Officer (CMO) of Pune-based Sassoon General Hospital were arrested for alleged manipulation of the blood sample of the teen driver, the Maharashtra government has informed a local court that it has permitted the Pune police to prosecute them and another staffer from the hospital. 

According to a recent news agency report, these trio, the juvenile’s parents and two middlemen are currently in jail in the case. The three staffers of Sasson Hospital are accused of being involved in the swapping of the minor’s blood samples to nullify alcohol tests. 

Medical Dialogues team had earlier reported that two doctors of Sassoon Hospital were arrested for allegedly discarding the blood samples of the 17-year-old boy suspect accused of murdering two software engineers and replacing them with another person’s samples.

Also read- Porsche Crash Case: Need official documents to initiate action against Forensic Head, CMO of Sassoon Hospital, says Medical Council

The two doctors accused of tampering with the blood sample reports include the head of the Forensic Medicine department of Sassoon General Hospital and the chief medical officer of the Sassoon Hospital.

During the investigation, it was revealed that the Chief Medical Officer reportedly replaced the blood samples on the direction of the HOD on 19th May at around 11 am. The CMO allegedly threw the blood samples in a dustbin of the hospital and sent the blood samples of another person to the forensic lab. As a result, the report showed no alcohol traces of the accused. Later, the state government suspended them based on the recommendation of the Maharashtra Medical Education Department commissioner.

Special public prosecutor advocate Shishir Hiray told PTI, “We today (on Thursday) submitted to the court that police have received the state government’s sanction to prosecute Taware, Halnor and Ghatkamble in the case. Such sanction to prosecute or frame charges against government employees is mandatory.”

Medical Dialogues had reported that no action was taken so far against the head of the Forensic Medicine department and Chief Medical Officer (CMO) of Pune-based Sassoon General Hospital by the Maharashtra Medical Council (MMC) in connection with the alleged manipulation of the blood sample of the teen driver involved in the May 19 Porsche car crash case.

On May 2024 the MMC issued notices to both doctors after taking suo moto cognizance of the matter. In the notice, the council had demanded a written explanation within seven days from the two doctors providing details for their alleged negligence following which actions were said to be taken accordingly.

Although the council received responses from the doctors, it is currently unable to take action against them until it receives an official response from the Pune police Commissioner and the Directorate of Medical Education and Research (DMER) in the case.

Also read- Porsche Crash Case: Crime Branch opposes bail plea of suspended Forensic Head of Sassoon Hospital

Powered by WPeMatico

Medical Bulletin 26 October/ 2024

Here are the top medical news for the day:

Want to Preserve Brain Health? Address Sleep Problems: AAN Study

People in early middle age who have poor sleep quality, including having difficulty falling or staying asleep, have more signs of poor brain health in late middle age, according to a study published online in Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that poor sleep accelerates brain aging. It only shows an association between poor sleep quality and signs of brain aging.

The study included 589 people with an average age of 40 at the start of the study. Participants completed sleep questionnaires both at the beginning of the study and again five years later. Participants had brain scans 15 years after the study began.

Researchers reviewed participants’ responses to questions such as, “Do you usually have trouble falling asleep?” “Do you usually wake up several times at night?” and “Do you usually wake up far too early?” They recorded the number of six poor sleep characteristics for each participant: short sleep duration, bad sleep quality, difficulty falling asleep, difficulty staying asleep, early morning awakening and daytime sleepiness.

Participants were divided into three groups. Those in the low group had no more than one poor sleep characteristic. People in the middle group had two to three, and those in the high group had more than three. At the start of the study, about 70% were in the low group, 22% were in the middle and 8% were in the high group.

Researchers examined participants’ brain scans where the level of brain shrinkage corresponds to a specific age. Researchers used machine learning to determine the brain age for each participant.

After adjusting for factors such as age, sex, high blood pressure and diabetes, researchers found people in the middle group had an average brain age that was 1.6 years older than those in the low group, while those in the high group had an average brain age 2.6 years older.

Of the sleep characteristics, bad sleep quality, difficulty falling asleep, difficulty staying asleep and early morning awakening were linked to greater brain age, especially when people consistently had these poor sleep characteristics over five years.

Urine Test May Reveal Early Signs of Genitourinary Diseases: Study finds

According to a new study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford University, studying the RNA and other substances within urine can show changes in cell types, revealing early signs of cancer and other diseases. This method could help clinicians detect problems earlier when they are more easily treated without invasive procedures.

“The current gold standard for detecting many genitourinary ailments is a biopsy where small tissue is removed during a rectal exam and sent to the lab for analysis. The invasive nature of the test can scare some people from getting the care they need,” said Joseph Buonomo, assistant professor of chemistry at UTA and an author of the study. “Our preliminary research shows that studying the RNA found in urine can detect some ailments in their earliest stages where they are easily—and cost effectively—managed.”

In the study, the team collected urine samples from two groups of people – healthy individuals and people with kidney stones. Researchers took two types of RNA from the urine – cell-free RNA that floats freely in urine, and sediment RNA, which comes from solid particles. The types of RNA were then sequenced and analyzed, comparing the specimens from the healthy individuals to the ones with kidney stones. They found that advanced urine analyses identified patterns in cells indicative of whether a person has disease.

“We’re excited about this new research as it may lead to new, easier screening tools that can help detect diseases of the bladder, kidneys, and prostate,” said Buonomo. “Although our patient cohort was small, it lays the groundwork for development of a type of ‘non-invasive liquid biopsy’ that will be used to track the progression of ailments like kidney stones, diabetes, and cancer using urine instead of surgical specimens.”

Reference: Sevahn K Vorperian, Brian C DeFelice, Joseph A Buonomo, Hagop J Chinchinian, Ira J Gray, Jia Yan, Kathleen E Mach, Vinh La, Timothy J Lee, Joseph C Liao, Richard Lafayette, Gabriel B Loeb, Carolyn R Bertozzi, Stephen R Quake, Deconvolution of Human Urine across the Transcriptome and Metabolome, Clinical Chemistry, 2024;, hvae137, https://doi.org/10.1093/clinchem/hvae137

Why Our Brains Are Effective at Quickly Processing Short Messages?

A new study by a team of New York University linguistics and psychology researchers has discovered that when a brief sentence is flashed, our brains detect its basic linguistic structure extremely quickly — in roughly 150 milliseconds, or about the speed of a blink of an eye.

“Our experiments reveal that the brain’s language comprehension system may be able to perceive language similarly to visual scenes, whose essence can be grasped quickly from a single glance,” says Liina Pylkkänen, a professor in NYU’s Department of Linguistics and Department of Psychology, who led the research, which is reported across papers appearing in Science Advances and the Journal of Neuroscience. “This means the human brain’s processing capacity for language may be much faster than what we might think — in the amount of time it takes to hear one syllable, the brain can actually detect the structure of a short sentence.”

The scientists began their research by considering current scientific explanations of how we understand language, which center on word-by-word sentence processing models. The researchers concluded these don’t effectively account for how quickly our brains can process entire sentences seen at a glance, as opposed to word by word like in speech.

In seeking a better understanding, the authors conducted a series of experiments, measuring brain activity using magnetoencephalography while participants read word lists that were either grammatical sentences or just lists of nouns. The results showed that the brain’s left temporal cortex — used for language comprehension — starts distinguishing simple three-word sentences from unstructured word lists as quickly as 130 milliseconds after seeing them.

“This speed suggests that at-a-glance sentence comprehension may resemble the rapid perception of a visual scene rather than the slower, step-by-step process we associate with spoken language,” explains Pylkkänen. “In the amount of time that it takes one to hear one syllable, the brain can actually detect the structure of a three-word sentence.”

Can Loss of Sleep Impact Brain Development in Babies?

A new study led by Sean Gay, a graduate student in the lab of Graham Diering, PhD, assistant professor in the Department of Cell Biology and Physiology at the UNC School of Medicine, has given us insights into how sleep loss during early life impacts key parts of brain development – and how it can also increase one’s risk for developing autism spectrum disorder (ASD). Their findings were published in the Proceedings of the National Academy of Sciences.

“The unique effects of sleep loss during development are largely unexplored,” said Diering. “Our data show that babies and children are more vulnerable to the negative effects of sleep disruption. We also found that sleep loss during this crucial period of time can negatively interact with underlying genetic risk for autism spectrum disorder.”

Diering has long studied how sleep strengthens synapses over time – a process termed synaptic plasticity – and how lack of sleep can contribute to cognitive and neurodegenerative disorders. If researchers could better understand the links between sleep and ASD, researchers and physicians also could make earlier diagnoses and come up with new treatment strategies for the disorder.

Using specialized mouse houses with highly sensitive sensors, researchers were able to carefully track mouse movements and breathing, allowing the researchers to keep score of wake and sleep states.

Researchers showed that when the adult mouse models lost a significant amount of sleep, they compensated for it by increasing sleep later during their regular active hours. Termed “sleep rebound”, this response allowed the adults to “make up” for lost sleep.

The younger mice; on the other hand, lacked sleep rebound entirely. This confirmed the researcher’s hypothesis that the younger mice might be more susceptible to the harmful effects of sleep deprivation. Researchers also noted that sleep deprivation in young mice completely impaired their performance in a learning memory task, whereas adults were far more resilient after sleep loss.

Reference: Gay, S. M., Chartampila, E., Lord, J. S., Grizzard, S., Maisashvili, T., Ye, M., … & Diering, G. H. (2023). Developing forebrain synapses are uniquely vulnerable to sleep loss. bioRxiv, 2023-11.

Powered by WPeMatico

Biocon Foundation Wins 2024 Doing Good for Bharat Award in Healthcare for eLAJ Smart Clinics

Bengaluru: Biocon Foundation, the CSR arm of the Biocon Group of Companies, announced that it has received the esteemed ‘Doing Good for Bharat Awards’ 2024 in the Healthcare category for its eLAJ Smart Clinics initiative, which aims to reimagine healthcare for underserved communities. The award was presented at the 11th India CSR & ESG Summit, organized by CSRBOX in New Delhi. 

The award was received by Shefali Misra, Vice President – Corporate Affairs, Biocon on behalf of Biocon Foundation, from Shri Dinesh Gundu Rao, Hon’ble Minister of Health & Family Welfare, Government of Karnataka, Shri (Dr) Raj Bhushan Choudhary, Hon’ble Union Minister of State Jal Shakti, Government of India, and Hon’ble Padma Shri Savji Dholakia, Founder and Chairman, Hare Krishna Exports & Dholakia Foundation.
This accolade recognizes Biocon Foundation’s significant contributions to primary healthcare through its unique eLAJ – Smart Clinics and highlights its deep commitment to making a difference in the lives of people. Biocon Foundation launched eLAJ Smart Clinics program in 2016 to enhance evidence-based preventive and primary healthcare. It has catered to over one million people across seven districts in Karnataka, with 8.8 lakh patient visits by 3.4 lakh unique patients.
On receiving the award, Dr Anupama Shetty, Mission Director, Biocon Foundation said, “It is an immense honor to be recognized at the ‘Doing Good for Bharat Awards’ 2024 by CSR Box. This award reaffirms our commitment to eLAJ – our initiative focused on supporting the primary healthcare infrastructure for the underserved community. We believe that quality healthcare is a fundamental right and are grateful to CSRBOX and the esteemed jury for acknowledging our work and impact. This award motivates us to continue expanding our reach and enhancing healthcare services, ensuring that more people have access to the care they deserve. We remain dedicated to making a meaningful difference across communities.”
The ‘Doing Good for Bharat Awards’, celebrate outstanding achievements in areas such as climate, education, healthcare, rural development, and inclusion. This year’s award ceremony recognized impact professionals, businesses, government entities, and civil society organizations for their dedicated efforts in creating a more inclusive and sustainable Bharat. The Awards aim to inspire more organizations to take bold and innovative steps in addressing social and environmental challenges.
Bhomik Shah, Founder & CEO, CSRBOX, highlighted the importance of these awards, stating, “The ‘Doing Good for Bharat Awards’ spotlight organizations that are making meaningful, tangible impacts on the ground. We are thrilled to recognize Biocon Foundation for their exceptional work in the Healthcare category.”
More About eLAJ Smart Clinic Program
eLAJ Smart Clinics program was launched to strengthen the delivery of evidence-based preventive and primary healthcare. Health outreach is cornerstone of eLAJ, playing a critical role in extending program reach and connecting people to care at our facilities. These smart clinics have been embedded in government Primary Health Centers (PHCs) and further scaled up through partnerships with tertiary institutions and NGOs working at the grassroot levels. Through eLAJ Smart Clinics, Biocon Foundation has been strengthening public healthcare delivery by providing accessible, efficient, and technology-driven healthcare solutions.
The eLAJ Smart Clinics model entails (Information and Communication Technologies) ICT-enabled process innovations, improved diagnostics, and management of non-communicable diseases (NCDs), with strong focus on delivering quality healthcare services to tribal populations in Karnataka. It features an electronic medical record system that provides evidence-based, personalized and continuous care, along with AI-enabled point-of-care diagnostic tools. This is supported by comprehensive surveillance, awareness campaigns, and outreach efforts led by trained and well-equipped health navigators.
Impact assessments have shown that eLAJ model has improved service utilization, patient satisfaction, health awareness and health seeking behavior in patients. It has reduced the out-of-pocket health expenditure for the patients.
With Grant Thornton LLP, Sattva Consulting, Indian School of Development Management, SP Jain Institute of Management and Research and IORA Ecological Solutions as the Primary Screening Partners, the Doing Good for Bharat Awards, ensured fair and thorough evaluation of all applications, ensuring that only the most impactful and innovative initiatives were recognized for their meaningful contributions to society and the environment. This rigorous screening process helped maintain transparency and integrity, highlighting projects that truly embody the spirit of positive change across India.
Biocon Foundation, the Corporate Social Responsibility arm of Biocon, Biocon Biologics and Syngene International, has been working to empower marginalized communities since 2005. Biocon Foundation partners with society to promote social and economic inclusion. It has thus made significant investments in enhancing access to quality healthcare, education, and civic infrastructure along with environmental sustainability projects. Combined with field initiatives, these programs create momentum to elevate the marginalized sections of society. Over the years, Biocon Foundation has built a strong reputation for the quality of its programs and their impact in addressing the social, humanitarian, and environmental challenges facing India. To make a more meaningful impact, the Foundation regularly partners with government agencies and like-minded organizations for program delivery. Besides addressing critical national and state level challenges in primary healthcare, education and rural development, the Foundation is also augmenting environmental sustainability through the lake revival mission in Bengaluru. Visit: http://www.bioconfoundation.org
Curated by CSRBOX and NGOBOX, the India CSR Summit and ESG Forum is Asia’s largest CSR and Sustainability Forum, which brings together leaders from across the social impact spectrum to explore and discuss the evolving landscape of corporate social responsibility (CSR), sustainability and social impact. The three-day event features insightful panel discussions, informative keynote speeches, interactive workshops, and engaging networking opportunities, making it a must-attend event for anyone interested in CSR and sustainability space. The Summit was graced by 3000+ sector visionaries, thought leaders, professionals and change-makers committed to shaping the future of the Indian impact ecosystem through CSR, sustainability, and social impact. Learn more about India

Powered by WPeMatico

How the novel antibody felzartamab impacts IgA nephropathy

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase II trial revealed that felzartamab, an investigational anti-CD38 monoclonal antibody, helps to reduce proteinuria and maintain patients’ kidney function.

Powered by WPeMatico

Analyzing heart and kidney outcomes after canagliflozin treatment in older adults

Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with type 2 diabetes, but it is unclear whether their effects differ based on patients’ age.

Powered by WPeMatico

Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear.

Powered by WPeMatico